Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression of estrogen and progesterone receptor (ER/PR), as well as human epidermal growth factor receptor (HER-2), accounting for about 20% of the total diagnosed breast cancers in the world [1,2]. This evidence concerns the gene PGR and breast carcinoma.